Table 3.
ID | Pre Therapy | 12 Months Evaluation | Recurrence | |||||||
---|---|---|---|---|---|---|---|---|---|---|
ATA Risk Category | Tg | Tg | US | Diagnostic WBS Uptake |
Response to Therapy | Site | Months | Tg | Treatment | |
1 | Intermediate | 184 | 11 | − | TB | BIR | TB | 48 | 70 | RAI |
2 | Intermediate | 12 | 6 | − | TB | BIR | TB | 32 | 13 | RAI |
3 | Intermediate | 18 | 53 | − | TB | BIR | TB | 67 | 13 | RAI |
4 | Intermediate | 72 | 1.5 | − | TB | BIR | TB | 19 | 14 | RAI |
5 | Low | 32 | 1 | + | TB | SIR | TB | 18 | 29 | RAI |
6 | High | 73 | 1.4 | + | TB | BIR | TB | 90 | 11 | RAI |
7 | Intermediate | 36 | 7 | + | TB | IR | TB | 10 | 12 | RAI |
8 | Intermediate | 13 | 1.4 | − | TB | IR | TB | 17 | 9.1 | RAI |
9 | Low | 41 | 3 | − | TB | IR | TB | 17 | 59 | RAI |
10 | Intermediate | 24 | 0.1 | − | TB | ER | TB | 15 | 12 | RAI |
11 | Intermediate | 0.5 | 0.2 | − | TB | ER | TB | 17 | 28 | RAI |
12 | Intermediate | 51 | 2 | + | TB | SIR | TB and LN | 13 | 7.6 | RAI |
13 | High | 36 | 0.5 | − | − | BIR | TB and LN | 29 | 15 | RAI |
14 | Intermediate | 1 | 2 | − | − | BIR | TB and LN | 13 | 37 | RAI |
15 | Intermediate | 0.5 | 0.3 | − | − | IR | TB and LN | 25 | 8 | RAI |
16 | High | 320 | 11 | − | − | IR | TB and LN | 26 | 5.6 | RAI |
17 | High | 14 | 4.5 | − | − | IR | Bone | 73 | 330 | RAI |
18 | High | 1.1 | 1.4 | − | Thorax | IR | Bone | 19 | 49 | RAI |
19 | High | 19 | 2 | − | Thorax | BIR | Lung | 60 | 440 | RAI |
20 | Intermediate | 28 | 8 | − | Thorax | BIR | Lung | 11 | 83 | RAI |
21 | High | 102 | 5.2 | − | Thorax | BIR | Lung | 21 | 113 | RAI |
22 | High | 112 | 1.2 | − | Thorax | IR | Lung | 33 | 62 | RAI |
23 | High | 215 | 0.2 | − | Mediastinum | ER | Mediastinal LN | 17 | 30 | RAI |
24 | High | 2 | 4 | − | Mediastinum | BIR | Mediastinal LN | 16 | 8 | RAI |
25 | High | 67 | 45 | − | Mediastinum | BIR | Paratracheal LN | 25 | 9,7 | RAI |
26 | Intermediate | 14 | 0.7 | − | LN | IR | TB and LN | 18 | 4.2 | Surgery + RAI |
27 | High | 48 | 0.1 | − | TB | IR | TB and LN | 27 | 1.1 | Surgery + RAI |
28 | High | 0.8 | 0.2 | − | LN | ER | LC LN | 112 | 236 | Surgery + RAI |
29 | Intermediate | 24 | 0.1 | − | − | ER | LC LN | 12 | 6,1 | Surgery + RAI |
30 | Intermediate | 14 | 1.3 | + | − | BIR | LC LN | 56 | 4,7 | Surgery + RAI |
31 | High | 13 | 1.5 | − | TB | BIR | LC LN | 12 | 7,1 | Surgery + RAI |
32 | High | 64 | 1.2 | + | LN | IR | LC LN | 17 | 6,2 | Surgery + RAI |
33 | High | 6 | 5.1 | − | − | BIR | LC LN | 30 | 398 | Surgery + RAI |
34 | High | 37 | 20 | − | TB | BIR | LC LN | 12 | 196 | Surgery + RAI |
35 | Intermediate | 0.8 | 10 | − | TB | BIR | LC LN | 31 | 5,1 | Surgery + RAI |
36 | High | 0.5 | 2.5 | − | − | IR | LC LN | 55 | 2,2 | Surgery + RAI |
37 | High | 4 | 1.1 | − | − | IR | LC LN | 16 | 4,1 | Surgery + RAI |
38 | High | 3 | 0.6 | − | − | IR | LC LN | 32 | 9 | Surgery + RAI |
39 | Intermediate | 31 | 0.1 | + | LN | IR | LC LN | 19 | 10 | Surgery + RAI |
40 | Intermediate | 0.5 | 0.9 | − | − | IR | LC LN | 86 | 4,1 | Surgery + RAI |
41 | Intermediate | 7 | 8 | − | − | BIR | LC LN | 95 | 4 | Surgery + RAI |
42 | Intermediate | 51 | 0.2 | − | TB | ER | LC LN | 10 | 7 | Surgery + RAI |
Tg (thyroglobulin), TB (thyroid bed), LN (lymph nodes), LC (latero-cervical), RAI (radioactive iodine), US (ultrasound), ER (excellent response), IR (indeterminate response), BIR (biochemical incomplete response) SIR (structural incomplete response); +/−: presence/absence of thyroid residual tissue.